b.research
A powerful, flexible platform for decentralized and hybrid studies
Empower the patient and deliver new value-based outcomes
b.research enables you to conduct traditional, decentralized and hybrid studies in a secure and reliable way with increased data quality:
- Full EDC platform including eCRF, eCOA, eCEC, and Imagery
- Full suite of features for decentralized and hybrid clinical studies — eConsent, ePRO, and seamless integration with IoT and sensors
- 40+ generic health surveys included (SF36v2, SF12v2, EQ5D5L, etc.) for faster study start up times
- Superior patient engagement and retention thanks to timeline feature, push notification, reminders and more
A single, unified SaaS solution
Optimized for all EU Phase IV, Real-World Evidence, Early Access Program, Post-Approval studies and all therapeutic areas for Pharma, Biotech, Medtech, and Contract Research Organizations.
Increase your patients' comfort
Enjoy high flexibility
Benefit from fast and easy set-up for reduced timelines
Provide smooth user experience
Over 10 years of the most friendly and compliant patient-reported outcomes (PROs) with 50 studies and 20K+ patients enrolled
- User-friendly clinical workflow makes it easy for clinicians to invite patients to participate and access their records in real-time
- Full EDC platform including eCRF, eCOA, eCEC, eImagery
- Hybrid Decentralized Clinical Studies (eConsent), patient recruitment, and patient engagement (eDiary/eSensor) and IoT hub
- 40+ generic health surveys included (SF36v2, SF12v2, EQ5D5L, etc.) for faster study start up times
- Timeline, Push Notification, Reminders and more
- Available through web and mobile / tablet (Android and Apple store)
- Highly flexible solution
- Fast and easy set-up including do-it-yourself capabilities
- Compliant with regulations (21 CFR part 11) and Europeans laws (GDPR, GCP)
